Impax Laboratories (IPXL) Tops Q3 EPS by 3c

November 9, 2017 7:05 AM EST

Impax Laboratories (NASDAQ: IPXL) reported Q3 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $206.4 million versus the consensus estimate of $208.36 million.

For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings